p38 MAPK Recombinant Antbody Kit (KD-Validated)
Applications
Reactivity
| Overview | |
| Catalog # | bsm-90194r-50uL |
| Product Name | p38 MAPK Recombinant Antbody Kit (KD-Validated) |
| Applications |
WB
FCM
IC
|
| Specificity | Knockdown Validated |
| Reactivity | Human, Mouse, Rat |
| Specifications | |
| Conjugation | Unconjugated |
| Host | Rabbit |
| Source | A synthesized peptide derived from human p38 MAPK |
| Immunogen Range | 150-250/360 |
| Clonality | Recombinant |
| Isotype | IgG |
| Concentration | Lot dependent |
| Purification | Affinity Purified |
| Storage Buffer | 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| Storage Condition | -20°C |
| Target | |
| Gene ID | 1432 |
| Swiss Prot | Q16539 |
| Synonyms | MAPK14; Mitogen-Activated Protein Kinase 14; PRKM14; PRKM15; CSBP1; CSBP2; CSPB1; P38; Mitogen-Activated Protein Kinase P38 Alpha; MAX-Interacting Protein; CSAID-Binding Protein; MAP Kinase P38 Alpha; P38 MAP Kinase; MAP Kinase 14; EC 2.7.11.24; SAPK2A; Mxi2; CSBP; MXI2; Cytokine Suppressive Anti-Inflammatory Drug Binding Protein; Cytokine Suppressive Anti-Inflammatory Drug-Binding Protein; P38 Mitogen Activated Protein Kinase; Stress-Activated Protein Kinase 2A; Stress-Activated Protein Kinase 2a; MAP Kinase Mxi2; MAP Kinase MXI2; P38alpha Exip; EC 2.7.11; P38ALPHA; MAPK 14; SAPK2a; EXIP; RK |
| Background | Cell Line: HT-1080 Knockdown technology: shRNA Knockdown |
| Application Dilution | |
| WB | 1:300-5000 |
| FCM | 1:20-100 |
| IC | 1:1000 |